{"id":1279,"date":"2022-03-23T18:25:06","date_gmt":"2022-03-23T18:25:06","guid":{"rendered":"https:\/\/people.unica.it\/iaaass\/?p=1279"},"modified":"2022-03-23T18:25:06","modified_gmt":"2022-03-23T18:25:06","slug":"5h-iaaass-program","status":"publish","type":"post","link":"https:\/\/people.unica.it\/iaaass\/2022\/03\/23\/5h-iaaass-program\/","title":{"rendered":"5h IAAASS Program"},"content":{"rendered":"

Download the abstract book: 5th IAAASS Program & Abstract book<\/a><\/span><\/p>\n

 <\/p>\n

WEDNESDAY, SEPTEMBER 22<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

ALL TIMES ARE LOCAL (SARDINIA STANDARD TIME)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

5 \u2013 5:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Opening Remarks<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Enzo Tramontano, <\/strong>University of Cagliari, Italy<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reuben Harris, <\/strong>HHMI and University of Minnesota, United States<\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

5:10 \u2013 6:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Opening Plenary\u00a0 <\/strong><\/p>\n

 <\/p>\n

1 \u2013 Akiko Iwasaki<\/strong>, Yale School of Medicine, United States \u201cImmune responses to SARS-CoV-2\u201d<\/p>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

THURSDAY, SEPTEMBER 23<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

ALL TIMES ARE LOCAL (SARDINIA STANDARD TIME)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

9:55 \u2013 10:00 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Opening Remarks <\/strong><\/p>\n

 <\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reuben Harris, <\/strong>HHMI and University of Minnesota, United States<\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

10:00 \u2013 11:00 AM\u00a0 \u00a0\u00a0\u00a0 Breakout Session 1 – <\/strong>\u00a0<\/strong>Individual Breakout Rooms 1-10<\/strong><\/p>\n

 <\/p>\n

2 \u2013 Low Zhao Xuan<\/strong>, Sunway University, Malaysia \u201cAntiviral activity of silymarin, baicalein and baicalin against Dengue virus\u201d<\/p>\n

 <\/p>\n

3 \u2013 Nicol\u00f2 Santi<\/strong>, Cardiff University, United Kingdom \u201cIdentification of novel non-nucleoside inhibitors of Dengue virus NS5 RNA-dependent RNA polymerase\u201d<\/p>\n

 <\/p>\n

4 \u2013 Saverio Lemme<\/strong>, MIMIT \u2013 Tor Vergata, Italy \u201cAn application of the obtained comparison results from the analysis of three classes of patients pharmacologically treated and untreated to the structure of the HIV-1 integrase\u00a0 to obtain a deeper understanding of the observed mutations\u201d<\/p>\n

 <\/p>\n

5 \u2013 Saumya Singh<\/strong>, Sam Higginbottom University of Agriculture, Technology & amp; Sciences, India \u201cDesign and development of novel oxadiazole based 1,3,5-Triazines as NNRTI targeting entrance channel of NNRTI binding site \u201d<\/p>\n

 <\/p>\n

6 \u2013 Emmanuel Heilmann<\/strong>, Medical University Innsbruck, Austria \u201cCell-based cis-cleavage screening method for SARS-CoV-2 protease inhibitors\u201d<\/p>\n

 <\/p>\n

7 \u2013 Francesca Miglioli<\/strong>, University of Parma, Italy \u201cSynthesis of polyhydroxylated heterocyclic compounds as inhibitors of Influenza virus pan endonuclease\u201d<\/p>\n

 <\/p>\n

8 \u2013 Dominik Werz<\/strong>, University of Hambur, Germany \u201cLipophilically, bioreversibly masked cyclic nucleoside monophosphate derivatives – Tools for non-invasive cell assays\u201d<\/p>\n

 <\/p>\n

9 \u2013 Ekaterina Ryabchevskaya<\/strong>, Lomonosov Moscow State University, Russian Federation \u201cThe development of broad\u2011spectrum recombinant Betacoronavirus vaccine with plant virus\u2011based platform\u2011adjuvant\u201d<\/p>\n

 <\/p>\n

10 \u2013 Annalaura Paulis<\/strong>, University of Cagliari, Italy \u201cFlavonoids induce type I Interferon expression through STING dependent pathway\u201d<\/p>\n

 <\/p>\n

11 \u2013 Annalaura Brai<\/strong>, University of Siena, Italy \u201cExploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor\u201d<\/p>\n

 <\/p>\n

12 \u2013 Lia-Raluca Olari<\/strong>, Ulm University, Germany \u201cAn amyloidogenic fragment of human alpha hemoglobin with a combined antibacterial and antiviral activity\u201d<\/p>\n

 <\/p>\n

13 \u2013 Selina Pasquero<\/strong>, University of Turin, Italy \u201cNovel antiviral activity of PADs inhibitors against Beta-coronaviruses SARS-CoV-2 and HCoV-OC43\u201d<\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

Main Session 1:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cristina Parolin<\/strong>, University of Padua, Italy<\/p>\n

\u00a0<\/strong><\/p>\n

11:00 \u2013 11:10 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Overview of the session<\/p>\n

 <\/p>\n

11:10 \u2013 11:40 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14 \u2013 Graciela Andrei<\/strong>, KU Leuven, Belgium \u201cHerpesvirus DNA polymerases and impact of mutator phenotypes\u201d<\/p>\n

 <\/p>\n

11:40 \u2013 12:10 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 15 \u2013 Matteo Iannacone<\/strong>, Vita-Salute San Raffaele University, Italy \u201cControlled administration of aerosolized SARS-CoV-2 to K18-hACE2 transgenic mice uncouples respiratory infection and anosmia from fatal neuroinvasion\u201d<\/p>\n

 <\/p>\n

12:10 \u2013 12:40 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 16 \u2013 Ali Mirazimi,<\/strong> Karolinska Institutet, Sweden \u201cUsing recombinant human\u00a0Angiotensin-Converting Enzyme 2\u00a0\u00a0(rhACE-2) as antiviral against SARS-CoV 2\u201d<\/p>\n

 <\/p>\n

12:40 AM \u00a0\u2013 01:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0 17 \u2013 Roberto Di Santo<\/strong>, Universit\u00e0 di Roma La Sapienza, Italy \u201cDesign of selective HIV-1 RNase H inhibitors starting form DKA dual inhibitors of IN and RNase H\u201d<\/p>\n

 <\/p>\n

01:10 \u2013 01:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 18 \u2013 Andrea Brancale<\/strong>, Cardiff University, United Kingdom \u201c Structure-based drug design in antiviral drug discovery\u201d<\/p>\n

\u00a0<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

01:40 \u2013 03:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Long break (breakout rooms 2-18 open for discussion)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

Main Session 2:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angela Corona, <\/strong>University of Cagliari, Italy<\/p>\n

\u00a0<\/strong><\/p>\n

03:00 \u2013 03:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Overview of the session<\/p>\n

\u00a0<\/strong><\/p>\n

03:10 \u2013 03:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 19 \u2013 Jason McLellan<\/strong>, University of Texas Austin, United States \u201cStructural approaches to SARS-CoV-2 therapy and strategies to address the inevitability of resistance\u201d<\/p>\n

 <\/p>\n

03:40 \u2013 04:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 20 \u2013 Reuben Harris<\/strong>, HHMI and University of Minnesota, United States \u201cInnovative herpesviral mechanisms to escape restriction by cellular APOBEC enzymes\u201d<\/p>\n

 <\/p>\n

04:10 \u2013 04:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 21 \u2013 Katherine Seley-Radtke<\/strong>, University of Maryland, United States\u00a0 \u00a0\u201cRational (and sometimes irrational!) strategies in nucleoside drug design\u201d<\/p>\n

 <\/p>\n

04:40 \u2013 05:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 22 \u2013 St. Patrick Reid<\/strong>, Omaha University, United States\u00a0 \u201cElucidating the pathogenic mechanisms of chikungunya virus\u201d<\/p>\n

 <\/p>\n

05:10 \u2013 05:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 23 \u2013 Peter Stockley<\/strong>, University of Leeds, United Kingdom \u201cStructural & functional investigations of a murderous viral enzyme in a native-like context\u201d<\/p>\n

 <\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

05:40 \u2013 06:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Short break (breakout rooms 19-23 open for discussion)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

06:00 \u2013 07:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0 Breakout Session 2 – <\/strong>\u00a0<\/strong>Individual Breakout Rooms 21-30<\/strong><\/p>\n

 <\/p>\n

24 \u2013 Alessia Onali<\/strong>, University of Cagliari, Italy \u201cInhibitors of HIV-1 RT: exploring new scaffolds for the dual inhibitionof polymerase and ribonuclease associated functions\u201d<\/p>\n

 <\/p>\n

25 \u2013 Charles Waters<\/strong>, University of Maryland, United States \u201cSynthesis of flexible nucleos(t)ide analogues of remdesivir in broad specturm antiviral therapeutics\u201d<\/p>\n

 <\/p>\n

26 \u2013 Elisa Fanunza<\/strong>,University of Minnesota, United States \u201cHuman cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism\u201d<\/p>\n

 <\/p>\n

27 \u2013 L<\/strong>uisa Fernanda Duarte Pe\u00f1aloza<\/strong>, Pontificia Universidad Cat\u00f3lica Chile,\u00a0Chile\u00a0 \u201cCharacterization of vaccine breakthrough cases exhibited in a cohort of Chilean adults immunized with an inactivated SARS-CoV-2 vaccine\u201d<\/p>\n

 <\/p>\n

28 \u2013 Nathan Ponzar<\/strong>, Saint Louis University, United States \u201cComplex inhibition characteristics of HBV and HIV RibonucleasE H inhibitors against human ribonuclease H1\u201d<\/p>\n

 <\/p>\n

29 \u2013 Sante Scognamiglio<\/strong>, University of Cagliari, Italy \u201cIdentification, comprehensive characterization and comparative genomics of the HERV-K(HML8) integrations in the human genome\u201d<\/p>\n

 <\/p>\n

30 \u2013 Tyng Hwey Tan<\/strong>, University of Aberdeen, United Kingdom \u201cMonoclonal human antibodies that recognise the exposed N and C terminal regions of the often-overlooked SARS-COV-2 ORF3a transmembrane protein\u201d<\/p>\n

 <\/p>\n

31 \u2013 Seyad Arad Moghadasi<\/strong>, University of Minnesota, United States \u201cGain-of-function assay for SARS-CoV-2 Mpro\u00a0inhibition in living cells\u201d<\/p>\n

 <\/p>\n

32 \u2013 Desiree Rijono<\/strong>, University of Hamburg,\u00a0Germany \u201cOptimization of a phenylethynyl anthranilic acid based dihydroorotate dehydrogenase inhibitor series for the use as antiviral agent\u201d<\/p>\n

 <\/p>\n

33 \u2013 Benedikt Ganter<\/strong>, University of Hamburg,\u00a0Germany\u00a0 \u201cThesis of modified T-1106-5\u00b4-triphosphates as potential inhibitors of the SARS-CoV-2 RNA polymerase\u201d<\/p>\n

 <\/p>\n

34 \u2013 Joy E. Thames<\/strong>, University of Maryland, United States \u201cDesign, synthesis, and biological evaluation of flex-acyclovir analogues against SARS-CoV-2\u201d<\/p>\n

 <\/p>\n

35 \u2013 Oriana Tabarrini<\/strong>, Universiy of Perugia, Italy \u201cExploiting a proprietary compound library to fight SARS-COV-2: identification of 2-phenylquinolines with pan-anticoronavirus activity\u201d<\/p>\n

 <\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

07:00 \u2013 09:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refreshments (breakout rooms 2-35 open for discussion)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

FRIDAY, SEPTEMBER 24<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

ALL TIMES ARE LOCAL (SARDINIA STANDARD TIME)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

11:55 \u2013 12:00 AM\u00a0\u00a0\u00a0\u00a0\u00a0 Opening Remarks <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Enzo Tramontano, <\/strong>University of Cagliari, Italy<\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

Main Session 3:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Elias Maccioni<\/strong>, University of Cagliari, Italy<\/p>\n

\u00a0<\/strong><\/p>\n

12:00 \u2013 12:10 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Overview of the session<\/p>\n

 <\/p>\n

12:10 \u2013 12:40 AM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 36 \u2013 Giorgio Gribaudo<\/strong>, University of Torino, Italy \u201cThe US12\u00a0protein family of the Human Cytomegalovirus: from functions to antiviral intervention\u201d<\/p>\n

 <\/p>\n

12:40 AM \u2013 01:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 37 \u2013 Branka Horvat<\/strong>, International Center for Infectiology Research-CIRI, France \u201cDevelopment of fusion inhibitory peptides against airborne viral infections, measles and COVID-19\u201d<\/p>\n

 <\/p>\n

01:10 \u2013 01:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 38 \u2013 Luis Menendez- Arias<\/strong>, Centro de Biolog\u00eda Molecular Severo Ochoa, Madrid, Spain \u201cHIV-1 replication: fidelity, drug resistance and unexploited antiviral targets\u201d<\/p>\n

 <\/p>\n

01:40 \u2013 02:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 39 \u2013 Vincenzo Summa<\/strong>, Federico II University, Italy \u201cA journey from HCV protease to SARS-CoV-2- 3Clp protease inhibitors in clinical trial: challenges and opportunities\u201d<\/p>\n

 <\/p>\n

02:10 \u2013 02:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 40 \u2013 Johan Neyts<\/strong>, KU Leuven, Belgium \u201cAntivirals, a lot has been achieved, yet a long way to go\u201d<\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

02:40 \u201304:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Long break (breakout rooms 36-40 open for discussion)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

Main Session 4:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reuben Harris<\/strong>, HHMI and University of Minnesota, United States\u00a0 \u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

04:00 \u2013 04:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Overview of the session<\/p>\n

 <\/p>\n

04:10 \u2013 04:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 41 \u2013 Anne Simon<\/strong>, University of Maryland, United States\u00a0 \u00a0\u201cDeveloping novel virus-like agents to combat viral, bacterial, and other pathogens of trees to prevent a future without citrus, chocolate, grapevines and olives\u201d<\/p>\n

 <\/p>\n

04:40 \u2013 05:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 42 \u2013 Yun-Xing Wang<\/strong>, National Cancer Institute, United States\u00a0 \u00a0\u201cDirect visualization of individual RNA molecules and mapping the RNA conformational space in solution\u201d<\/p>\n

 <\/p>\n

05:10 \u2013 05:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 43 \u2013 Jos\u00e8 Est\u00e8 Araque<\/strong>, UIC, Spain \u201cIdentifying new antivirals, resistance and host-factors\u201d<\/p>\n

 <\/p>\n

05:40 \u2013 06:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 44 \u2013 Michelle Hastings<\/strong>, Rosalind Franklin University, United States\u00a0 \u00a0\u201cAntisense oligonucleotides for the control of gene expression in disease and infection\u201d<\/p>\n

 <\/p>\n

06:10 \u2013 06:40 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 45 \u2013 Luca Guidotti<\/strong>, Vita-Salute San Raffaele University, Italy \u201cAnimal models for the development of antiviral agents against hepatitis B virus (HBV)\u201d<\/p>\n

\u00a0<\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n

06:40 \u2013 08:00 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refreshments (breakout rooms 36-45 open for discussion)<\/strong><\/p>\n

 <\/p>\n

*******************************************************************************************************<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Download the abstract book: 5th IAAASS Program & Abstract book   WEDNESDAY, SEPTEMBER 22 \u00a0 ALL TIMES ARE LOCAL (SARDINIA STANDARD TIME)   *******************************************************************************************************   5 \u2013 5:10 PM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Opening Remarks \u00a0 Convener: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Enzo Tramontano, University of Cagliari, Italy \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reuben Harris, HHMI and University of Minnesota, United States   ******************************************************************************************************* 5:10 \u2013 […]<\/a><\/p>\n","protected":false},"author":116,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56376],"tags":[],"class_list":["post-1279","post","type-post","status-publish","format-standard","hentry","category-iaaass-2012-home","category-56376-id","post-seq-1","post-parity-odd","meta-position-corners","fix"],"geo":null,"_links":{"self":[{"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/posts\/1279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/users\/116"}],"replies":[{"embeddable":true,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/comments?post=1279"}],"version-history":[{"count":1,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/posts\/1279\/revisions"}],"predecessor-version":[{"id":1280,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/posts\/1279\/revisions\/1280"}],"wp:attachment":[{"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/media?parent=1279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/categories?post=1279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/people.unica.it\/iaaass\/wp-json\/wp\/v2\/tags?post=1279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}